Artificial intelligence in clinical research of cancers

22Citations
Citations of this article
119Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Several factors, including advances in computational algorithms, the availability of high-performance computing hardware, and the assembly of large community-based databases, have led to the extensive application of Artificial Intelligence (AI) in the biomedical domain for nearly 20 years. AI algorithms have attained expert-level performance in cancer research. However, only a few AI-based applications have been approved for use in the real world. Whether AI will eventually be capable of replacing medical experts has been a hot topic. In this article, we first summarize the cancer research status using AI in the past two decades, including the consensus on the procedure of AI based on an ideal paradigm and current efforts of the expertise and domain knowledge. Next, the available data of AI process in the biomedical domain are surveyed. Then, we review the methods and applications of AI in cancer clinical research categorized by the data types including radiographic imaging, cancer genome, medical records, drug information and biomedical literatures. At last, we discuss challenges in moving AI from theoretical research to real-world cancer research applications and the perspectives toward the future realization of AI participating cancer treatment.

Cite

CITATION STYLE

APA

Shao, D., Dai, Y., Li, N., Cao, X., Zhao, W., Cheng, L., … Zhao, J. (2022, January 1). Artificial intelligence in clinical research of cancers. Briefings in Bioinformatics. Oxford University Press. https://doi.org/10.1093/bib/bbab523

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free